Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Luxembourg Centre for Systems Biomedicine Appoints BIOBASE Genome Trax™ to Identify Human Genome Variations

Published: Wednesday, July 18, 2012
Last Updated: Wednesday, July 18, 2012
Bookmark and Share
Researchers in Luxembourg will use Genome Trax™ to analyze next generation sequencing variants in clinical diagnostics.

In addition, both groups will collaborate to establish a hub of expertise for the application of BIOBASE products and will provide data analysis, training, and support to researchers in Luxembourg and surrounding countries.

Genome Trax™ prioritizes human genome variants in whole genome or exome data that merit further investigation. The tool maps NGS data to known features such as disease mutations and regulatory sites. In addition, Genome Trax™ identifies novel mutations that are likely to affect the function of candidate disease genes, and enables users to filter out the millions of irrelevant variants.

Reinhard Schneider, Head of the Bioinformatics core facility at the LCSB, stated: “The mutation, regulation and pharmacogenomics data in Genome Trax™ are crucial for the annotation of our clinical data. These annotations are unparalleled in their comprehensiveness and quality, and I see this collaboration as a strategic partnership to advance the clinical application of NGS technology”.

"The LCSB is turning into one of the leading centers for bioinformatics worldwide and the bioinformatics facility, led by Dr. Reinhard Schneider, needs to interpret large volumes of data from the life sciences. This undertaking is powered by massive hardware, and needs the best available software and databases. LCSB chose BIOBASE as a strategic partner and I am looking forward to this collaboration.” said Frank Schacherer, CTO of BIOBASE.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos